Cardiovascular Surgery

This channel includes news and new technology innovations for cardiac surgery. This includes coronary artery bypass grafts (CABG) and surgical valve replacements.

News | Cardiovascular Business

April 29, 2022 – Providing excellent care inside and outside of the traditional hospital is the new normal for patients ...

Home April 29, 2022
Home
News | Heart Failure

April 27, 2022 – The contractile and elastic properties of the heart are finely tuned. This is a prerequisite for the ...

Home April 27, 2022
Home
News | Artificial Heart

April 25, 2022 – There’s no safe way to get a close-up view of the human heart as it goes about its work: you can’t just ...

Home April 25, 2022
Home
News | Womens Cardiovascular Health

April 25, 2022 – Advancements in techniques and treatment have transformed care for patients with cardiovascular disease ...

Home April 25, 2022
Home
News | Heart Failure

April 12, 2022 — Vesicles secreted from human heart cells may repair damaged tissue and prevent lethal heart rhythm ...

Home April 12, 2022
Home
MedWatch, The FDA Safety Information and Adverse Event Reporting Program, announced that Pfizer is recalling Accuretic (quinapril hydrochloride/hydrochlorothiazide) tablets distributed by Pfizer as well as two authorized generics distributed by Greenstone (quinapril HCL and hydrochlorothiazide and quinapril HCl/hydrochlorothiazide) due to the presence of a nitrosamine, N-nitroso-quinapril, above the Acceptable Daily Intake level.
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

Here is what you and your colleagues found to be most interesting in the field of cardiology during the month of March ...

Home March 31, 2022
Home
News | Artificial Heart

March 28, 2022 — Carmat, the designer and developer of the world’s most advanced total artificial heart, aiming to ...

Home March 28, 2022
Home
In January, The University of Maryland School of Medicine (UMSOM) and the University of Maryland Medical Center (UMMC) successfully executed a groundbreaking porcine heart transplant procedure in a human. This was the first successful transplant of a genetically modified pig’s heart into a human patient.
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

Here is what you and your colleagues found to be most interesting in the field of cardiology during the month of ...

Home March 04, 2022
Home
In January, The University of Maryland School of Medicine (UMSOM) and the University of Maryland Medical Center (UMMC) successfully executed a groundbreaking porcine heart transplant procedure in a human. This was the first successful transplant of a genetically modified pig’s heart into a human patient.
Feature | Heart Failure | By Melinda Taschetta-Millane
Home February 16, 2022
Home
News | Pediatric Cardiology

January 15, 2022 – Babies who are born with only one functioning heart ventricle must undergo a series of three ...

Home February 15, 2022
Home
News | Cardiovascular Surgery

February 15, 2022 – A multicenter, retrospective database analysis suggests improved open abdominal aortic aneurysm (AAA ...

Home February 15, 2022
Home
News | Cardiovascular Business

February 11, 2022 — People who have heart artery-opening procedures, called coronary artery revascularization ...

Home February 11, 2022
Home
By far the two biggest news items from January included the first pig heart transplant into a human patient at the University of Maryland Medical Center, and the FDA clearance of Novarti's inclisiran (Leqvio) twice annual dose injectable LDL lowering drug.
Feature | By Dave Fornell, DAIC Editor

February 1, 2021 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) m ...

Home February 01, 2022
Home
Subscribe Now